TARK Biopharma Company Profile, Contacts & Intelligence

TARK Biopharma Overview

TARK Biopharma Co., Ltd., established in 2020, is dedicated to developing innovative new molecular entities (NMEs) to address unmet clinical needs. Leveraging artificial intelligence technology, we accelerate the drug development process, advancing from preclinical research to clinical stages. Our mission is to provide more effective treatment options for patients worldwide, enhancing their quality of life. 兆益生醫 (TARK Biopharma Co., Ltd.) 成立於2020年，致力於研發創新新分子實體（new molecular entities, NME）藥物，以解決臨床未滿足的醫療需求。我們運用人工智慧技術加速新藥開發流程，從臨床前研究推進至臨床階段，致力於為全球患者提供更有效的治療方案，提升生活品質。

Headquarters

新北市, Tw

Industry

Biotechnology Research

Founded

2020

NAICS

Research and Development in Biotechnology (except Nanobiotechnology)

Compare Similar Companies to TARK Biopharma

Explore companies in related markets and compare their industry and employee estimates.